D-1106-2023 Class II Terminated
FDA drug recall D-1106-2023 was initiated by TMC Acquisitions LLC dba Tailor Made Compounding on August 15, 2023 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated September 30, 2024). Affected quantity: 99 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- August 30, 2023
- Initiation Date
- August 15, 2023
- Termination Date
- September 30, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 99 vials
Product Description
NAD+ 200mg/ml, 10ml vials, Tailor Made Compounding.
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide within the USA
Code Information
Lot#: 07192307A2, BUD: 11/18/2023